On Tuesday, Altimmune Inc (NASDAQ: ALT) opened higher 2.07% from the last session, before settling in for the closing price of $5.80. Price fluctuations for ALT have ranged from $2.09 to $14.84 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 115.21% annually for the last half of the decade. Company’s average yearly earnings per share was noted 7.32% at the time writing. With a float of $70.34 million, this company’s outstanding shares have now reached $70.68 million.
In an organization with 59 employees, it is important to assess its efficiency.
Altimmune Inc (ALT) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Altimmune Inc is 0.80%, while institutional ownership is 56.65%. The most recent insider transaction that took place on Aug 15 ’23, was worth 862. In this transaction Director of this company bought 300 shares at a rate of $2.88, taking the stock ownership to the 29,785 shares.
Altimmune Inc (ALT) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.14 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 7.32% per share during the next fiscal year.
Altimmune Inc (NASDAQ: ALT) Trading Performance Indicators
Check out the current performance indicators for Altimmune Inc (ALT). In the past quarter, the stock posted a quick ratio of 16.55. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1022.86.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.59, a number that is poised to hit -0.35 in the next quarter and is forecasted to reach -1.56 in one year’s time.
Technical Analysis of Altimmune Inc (ALT)
Let’s dig in a bit further. During the last 5-days, its volume was 2.23 million. That was inferior than the volume of 4.45 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 26.33%. Additionally, its Average True Range was 0.54.
During the past 100 days, Altimmune Inc’s (ALT) raw stochastic average was set at 11.04%, which indicates a significant decrease from 28.01% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 68.93% in the past 14 days, which was lower than the 85.07% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $6.74, while its 200-day Moving Average is $7.45. However, in the short run, Altimmune Inc’s stock first resistance to watch stands at $6.14. Second resistance stands at $6.37. The third major resistance level sits at $6.60. If the price goes on to break the first support level at $5.68, it is likely to go to the next support level at $5.45. Assuming the price breaks the second support level, the third support level stands at $5.22.
Altimmune Inc (NASDAQ: ALT) Key Stats
There are currently 70,902K shares outstanding in the company with a market cap of 419.37 million. Presently, the company’s annual sales total 430 K according to its annual income of -88,450 K. Last quarter, the company’s sales amounted to 10 K and its income totaled -24,390 K.
